Discover 2,427 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,427
Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
for
Neurofibromatosis 1
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT04750928
Phase 1, Phase 2, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Bethesda MD, Washington D.C. DC, Winchester VA,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase 3, Recruiting
Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
for
Severe Aplastic Anemia, Telomere Biology Disorders,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 2 - 70+
Code: NCT05012111
Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Bethesda MD, Fairfax VA, Fort Belvoir VA, Midlothian VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06350097
Phase 3, Recruiting
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
for
Hearing Loss, Head and Neck Cancer
Location: Bethesda MD, Fairfax VA, Baltimore MD, Rochester NY,
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)
Sex: All
Age: 18 - 70+
Code: NCT04915183
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Deep Brain Stimulation Therapy in Movement Disorders
for
Parkinson's Disease
Location: Bethesda MD
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Sex: All
Age: 18 - 70+
Code: NCT02119611
Recruiting
Psychological Treatments for Youth With Severe Irritability.
for
Irritability
Location: Bethesda MD
Sponsor: National Institute of Mental Health (NIMH)
Sex: All
Age: 8 - 17
Code: NCT02531893
Recruiting
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
for
Prostate Cancer, Biochemically Recurrent
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: Male
Age: 18+
Code: NCT05588128
Recruiting
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
for
Prostate Adenocarcinoma
Location: Bethesda MD, Baltimore MD, Richmond VA, Myrtle Beach SC,
Sponsor: Alessa Therapeutics Inc.
Sex: Male
Age: 21+
Code: NCT06257693
Phase 1, Recruiting
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
for
Chronic Granulomatous Disease
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 4 - 65
Code: NCT05463133
Phase 1, Phase 2, Recruiting
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
for
HIV
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT00029445
Recruiting
Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
for
Somatostatin Receptor Positive,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT06427798
Phase 1, Phase 2, Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
for
Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04002947
Phase 2, Recruiting
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
for
Severe Aplastic Anemia (SAA),
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 4 - 70+
Code: NCT03520647
Phase 2, Recruiting
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
for
Malaria, Intestinal Worms, GI Protozoa, Echiniococcus,
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)